[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367779-105":59,"doc-detail-367779-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","global-research-landscape-of-retinoblastoma-biomarkers-a-multidisciplinary-bibliometric-analysis-based-on-multiple-databases-20052025","Global research landscape of retinoblastoma biomarkers: a multidisciplinary bibliometric analysis based on multiple databases (2005–2025)","","Objective: Systematic quantitative analysis of how retinoblastoma (RB) biomarkers specifically affect RB outcomes remains limited. This study charts RB biomarker research from 2005–2025, identifying research landscape and hotspots to support future investigations. Methods: Publications were retrieved from Web of Science and Scopus (2005–2025), then analyzed with R, VOSviewer, and CiteSpace. Results: Output increased steadily, with key collaboration patterns and defined topic hotspots. Conclusion: Biomarkers are emerging tools for personalized management and are expected to shape future RB research.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/global-research-landscape-of-retinoblastoma-biomarkers-a-multidisciplinary-bibliometric-analysis-based-on-multiple-databases-20052025/367779/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/global-research-landscape-of-retinoblastoma-biomarkers-a-multidisciplinary-bibliometric-analysis-based-on-multiple-databases-20052025/367779.png","ImageObject",300,407,{"name":92,"@type":93},"Mimi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of this study on retinoblastoma biomarkers?","Question",{"text":112,"@type":113},"To map the research landscape and identify hotspots of RB biomarkers from 2005 to 2025, providing theoretical references for future work.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which databases and tools were used to analyze the publications?",{"text":117,"@type":113},"Publications were retrieved from Web of Science and Scopus, then analyzed using R software, VOSviewer, and CiteSpace.",{"name":119,"@type":110,"acceptedAnswer":120},"What trends and leading regions were reported in publication output?",{"text":121,"@type":113},"Publication output increased steadily, with faster growth from 2013–2021. China led in publication volume, while the United States contributed a broader international collaboration network.",{"name":123,"@type":110,"acceptedAnswer":124},"What are the main research hotspots and biomarker investigation directions?",{"text":125,"@type":113},"Hotspots include liquid biopsy/circulating tumor biomarkers, molecular subtyping and heterogeneity, targeted therapy and resistance, tumor microenvironment and immune evasion, and AI multimodal integration. Biomarker investigations focus on reflecting tumor burden dynamics, regulating oncogene processes, driving EMT and proliferation, mediating immune evasion, and deep-learning identification of heterogeneity.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},367779,1790439247,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},2336477974920,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Journal of Cancer Research and Clinical Oncology (2025) 151:231  \n[https://doi.org/10.1007/s00432-025-06279-7](https://doi.org/10.1007/s00432-025-06279-7)  \nRESEARCH  \nGlobal research landscape of retinoblastoma biomarkers: a multidisciplinary bibliometric analysis based on multiple databases (2005–2025)  \nZhixin Peng1,2 · Qi Hu1,3 · Xiangdong Chen2  \nReceived: 27 June 2025 / Accepted: 26 July 2025 / Published online: 15 August 2025 © The Author(s) 2025  \nAbstract  \nObjective Research exploring biomarkers for retinoblastoma (RB) diagnosis exists; however, their specific impact on RB has not been thoroughly investigated through systematic quantitative analysis. This study aims to analyze the research landscape and hotspots of RB biomarkers from 2005 to 2025, providing a theoretical reference for future investigations. Methods We retrieved publications from the Web of Science and Scopus databases published between 2005 and 2025, followed by analysis using R software, VOSviewer, and CiteSpace tools.  \nResults From 2005 to 2025, annual publication output exhibited a steady upward trajectory, with notably accelerated growth observed between 2013 and 2021, followed by a moderated pace from 2021 to 2024. China led in publication volume, followed by the United States, India, and Italy. While China dominated in quantitative output, the United States established abroader network of international collaborations. Cancers emerged as the journal with the highest publication count, whereas Cancer Research ranked first in citation frequency. Current research hotspots primarily include: liquid biopsy and circulating tumor biomarkers; molecular subtyping and tumor heterogeneity; targeted therapies and drug resistance mechanisms; tumor microenvironment and immune evasion; and artificial intelligence with multimodal data integration. Investigations into RB biomarkers focus on: (1) dynamically reflecting tumor burden (short half-life properties); (2) regulating oncogene transcription/translation (targeting E2F3, PI3K, and m6A); (3) driving epithelial-mesenchymal transition (EMT) and cellular proliferation; (4) mediating immune evasion; and (5) deep learning-based identification of tumor heterogeneity. The exploration of biomarkers to optimize individualized retinoblastoma treatment has emerged as a notable research trend.  \nConclusion As an emerging tool for achieving personalized therapeutic optimization, biomarkers have garnered significant attention from global scholars and are poised to become a major focus in future research on the management of RB. This study systematically reviewed and analyzed the current research landscape and key issues surrounding RB biomarkers, aiming to provide valuable references and insights for subsequent research in this field.  \nKeywords Biomarkers · Retinoblastoma · Precision medicine · Liquid biopsy · Tumor microenvironment  \n􀀍 Xiangdong Chen [1428616335@qq.com](1428616335@qq.com)  \n1 The First Clinical Chinese Medicine College of Hunan University of Chinese Medicine, Changsha, Hunan, China  \n2 The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China  \n3 Taizhou Traditional Chinese Medicine Hospital, Taizhou, Jiangsu, China  \nIntroduction  \nRetinoblastoma (RB) is the most common intraocular malignant tumor in infants and young children, originating from retinal photoreceptor precursor cells or retinal stem cells. It predominantly affects children under 3 years of age and exhibits a hereditary predisposition (Liu et al. 2024) . The pathological mechanism involves biallelic inactivation of the RB1 gene, which disrupts cell cycle regulation and triggers malignant proliferation of retinal precursor cells (He et al. 2020; Field et al. 2022) . This fundamental genetic alteration drives tumor heterogeneity and treatment  \nresistance, underscoring the critical need for biomarkers to guide precision therapies. Complications of retinoblastoma include secondary glaucoma, vision loss, structural d","cbCaisyjtvrDhX5m","https://ap.wps.com/l/cbCaisyjtvrDhX5m","pdf",1710239,13,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Disease background and molecular basis\n## Global burden and disparities\n## Current management strategies","[{\"question\":\"What is the main purpose of this study on retinoblastoma biomarkers?\",\"answer\":\"To map the research landscape and identify hotspots of RB biomarkers from 2005 to 2025, providing theoretical references for future work.\"},{\"question\":\"Which databases and tools were used to analyze the publications?\",\"answer\":\"Publications were retrieved from Web of Science and Scopus, then analyzed using R software, VOSviewer, and CiteSpace.\"},{\"question\":\"What trends and leading regions were reported in publication output?\",\"answer\":\"Publication output increased steadily, with faster growth from 2013–2021. China led in publication volume, while the United States contributed a broader international collaboration network.\"},{\"question\":\"What are the main research hotspots and biomarker investigation directions?\",\"answer\":\"Hotspots include liquid biopsy/circulating tumor biomarkers, molecular subtyping and heterogeneity, targeted therapy and resistance, tumor microenvironment and immune evasion, and AI multimodal integration. Biomarker investigations focus on reflecting tumor burden dynamics, regulating oncogene processes, driving EMT and proliferation, mediating immune evasion, and deep-learning identification of heterogeneity.\"}]","Global research landscape of retinoblastoma biomarkers: a multidisciplinary bibliometric analysis based on multiple databases (2005–2025) | PDF",1790172568,33,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/021951fa0a2efc88d514ee578bd83799.webp",983,1305,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2465b284bfb1c93ad7f723d8cb719b2.webp",982,1304,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/22804ca04fb42977383e8a0790e6616c.webp",981,1303,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e0e692b21785e3fd74913293906dd59.webp",980,1301]